Corcept Therapeutics Newsroom

Express News | Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

Reuters16:05 ET

Zacks.com Featured Highlights Include ADMA Biologics, American Superconductor, Biote, Lincoln Educational Services and Corcept Therapeutics

Yahoo FinanceJul 18 05:07 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Corcept Therapeutics (CORT) and Pfizer (PFE)

TipRanksJul 17 11:41 ET

Is Corcept Therapeutics Incorporated's (NASDAQ:CORT) Recent Stock Performance Tethered To Its Strong Fundamentals?

Simply Wall StJul 15 13:56 ET

Truist Financial Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)

TipRanksJul 15 07:15 ET

High Insider Ownership Growth Companies On US Exchanges In July 2024

Yahoo FinanceJul 11 07:01 ET

Corcept Therapeutics(CORT.US) Officer Sells US$162.45K in Common Stock

Moomoo NewsJul 3 17:59 ET

Corcept Therapeutics(CORT.US) Officer Sells US$324.9K in Common Stock

Moomoo NewsJul 3 17:54 ET

Corcept Therapeutics(CORT.US) Officer Sells US$357.39K in Common Stock

Moomoo NewsJul 3 17:34 ET

Corcept Therapeutics(CORT.US) Director Sells US$72,182 in Common Stock

Moomoo NewsJul 3 17:34 ET

Form 144 | Corcept Therapeutics(CORT.US) Officer Proposes to Sell 357.39K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Corcept Therapeutics(CORT.US)$ Officer Robb Gary Charles intends to sell 11,000 shares of its common stock on Jul 1, with a total market value of approximately $357.39K

Moomoo NewsJul 1 14:00 ET

Form 144 | Corcept Therapeutics(CORT.US) Officer Proposes to Sell 162.45K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Corcept Therapeutics(CORT.US)$ Officer Lyon Joseph Douglas intends to sell 5,000 shares of its common stock on Jul 1, with a total market value of approximately $162.45

Moomoo NewsJul 1 13:49 ET

Form 144 | Corcept Therapeutics(CORT.US) Officer Proposes to Sell 324.9K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Corcept Therapeutics(CORT.US)$ Officer Guyer William intends to sell 10,000 shares of its common stock on Jul 1, with a total market value of approximately $324.9K. G

Moomoo NewsJul 1 13:34 ET

Piper Sandler Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsJul 1 07:31 ET · Ratings

Corcept Therapeutics (CORT) Receives a Buy From Piper Sandler

TipRanksJul 1 06:36 ET

Corcept Therapeutics Announces Results From CATALYST Clinical Trial At ADA's 84th Scientific Sessions; Study Shows 24% Prevalence Of Hypercortisolism In Patients With Difficult-To-Control Type 2 Diabetes; Largest Study To Date With 1,055 Patients

BenzingaJun 24 16:16 ET

Express News | Corcept Therapeutics Inc - Results Demonstrate a Hypercortisolism Prevalence Rate of 24 Percent in This Patient Population

ReutersJun 24 16:16 ET

Express News | Corcept Announces Presentation of Results From Prevalence Phase of Catalyst Clinical Trial at American Diabetes Association’s Scientific Sessions

ReutersJun 24 16:15 ET

What Makes Corcept Therapeutics (CORT) a Good Investment Bet?

Yahoo FinanceJun 19 07:39 ET

6 Analysts Have This To Say About Corcept Therapeutics

BenzingaJun 17 15:00 ET